| 1 |
Enhanced liver functions of HepG2 cells in the alginate/xyloglucan scaffold
Deng XJ, Cao Y, Yan H, Yang JH, Xiong GM, Yao HC, Qi C
Biotechnology Letters, 37(1), 235, 2015 |
| 2 |
Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines
Castilho-Fernandes A, Fontes AM, Abraham KJ, de Freitas MCC, da Rosa NG, Picanco-Castro V, Russo-Carbolante EMD, Covas DT
Biotechnology Letters, 37(5), 991, 2015 |
| 3 |
Three Peptides from Soy Glycinin Modulate Glucose Metabolism in Human Hepatic HepG2 Cells
Lammi C, Zanoni C, Arnoldi A
International Journal of Molecular Sciences, 16(11), 27362, 2015 |
| 4 |
Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway
Wang GL, Fu YC, Xu WC, Feng YQ, Fang SR, Zhou XH
Biochemical and Biophysical Research Communications, 380(3), 644, 2009 |
| 5 |
Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1 alpha on the expression of apolipoprotein M in HepG2 cells
Xu N, Zhang XY, Dong X, Ekstrom U, Ye Q, Nilsson-Ehle P
Biochemical and Biophysical Research Communications, 292(4), 944, 2002 |
| 6 |
Paclitaxel administration and its effects on clinically relevant human cancer and non cancer cell lines
McAuliffe G, Roberts L, Roberts S
Biotechnology Letters, 24(12), 959, 2002 |
